PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Kuehne + Nagel on Brexit decision: “Free trade basis for prosperity”

  • No Brexit still the preferred solution
  • Risk of chaos following disorderly Brexit
  • Kuehne + Nagel well prepared to ensure flow of goods
Schindellegi / CH, January 16, 2019 – In response to the House of Commons vote in the UK, Dr. Detlef Trefzger, CEO of Kuehne + Nagel International AG, emphasises the importance of open markets.
“The House of Commons has made a historic decision which we need to respect. Kuehne + Nagel is committed to global free trade in principle which ensures prosperity for everyone. So from our perspective, “No Brexit” would be the preferred solution, since any form of Brexit is bound to increase trade barriers.
A disorderly Brexit is the worst solution. It will impose massive restrictions on the exchange of goods between the European Union and the United Kingdom. We appeal to the responsible bodies in London and Brussels to do the utmost to prevent this scenario. As far as we are concerned, we are focussed on ensuring the constant flow of goods for our customers”, says Trefzger.
Kuehne + Nagel has engaged customers and own industry experts over the past years to assess all possible impacts. In order to cope with the effects of a disorderly Brexit Kuehne + Nagel has taken steps to review all options to secure capacity on trade routes with Europe outside of the Kent corridor both by sea and air. Moreover, the company has commenced recruitment of additional customs clerks.
Kuehne + Nagel was asked to participate in the UK Government Cross Border Steering Group and will use this opportunity to define sustainable solutions as the set of Brexit conditions becomes clearer.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026